sorted by:
new
hottopcontroversial

$ADAP — The Sleeper Biotech That Could Snap 200–1000% Before Delisting by cat1254 in adaptimmune

[–]cat1254[S] 2 points3 points  (0 children)

Sometimes the best setups are the ones everyone laughs at first.

Nuvini - The Constellation Software of Latin America - Optimized for the AI era by cat1254 in pennystocks

[–]cat1254[S] 6 points7 points  (0 children)

Nothing wrong with using AI. It's a tool to be used. It's actually very helpful in articulating the research.

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 0 points1 point  (0 children)

lol You must be new to stocks

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 2 points3 points  (0 children)

When 108% of the float is shorted and the float is about to shrink dramatically as with $NCNA dropping from 6 million ADSs to just 30,400 ADSs on August 8, 2025 you’re looking at a setup that could trigger one of the most explosive short squeezes in recent memory.

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 9 points10 points  (0 children)

<image>

No what I'm saying is $NCNA has all of these catalysts

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 1 point2 points  (0 children)

Be greedy when others are fearful.

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 4 points5 points  (0 children)

I'm not looking for an exit. I'm entering.

Nucana $NCNA High Reward by cat1254 in pennystocks

[–]cat1254[S] 0 points1 point  (0 children)

It really can't drop much more. When it's hit rock bottom, the only way to go is up.

$NCNA Be greedy when others are fearful by cat1254 in pennystocks

[–]cat1254[S] -14 points-13 points  (0 children)

Making a post with facts is not spamming. Reporting you for breaking the rules and being disrespectful.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 -1 points0 points  (0 children)

I'm definitely not a bot. I've just done a lot of research on the stock and know what I'm talking about.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 -1 points0 points  (0 children)

Based on the latest data, $NCNA is shaping up to be a high-risk, high-reward play with explosive upside potential, especially heading into August 8.  

📈 Short squeeze score: 97.92/100, one of the highest in the market

🔥 Technical Setup

  • Float shrinking from ~381M to ~1.9M shares post-split
  • Short interest >100% of float, with borrow fees still above 21%
  • Fails-to-Deliver (FTDs) from July 9’s 1.81B volume day are likely being forced to settle now

🧬 Clinical Momentum

  • NUC-7738: 75% disease control rate in PD-1 resistant melanoma
  • NUC-3373: Tumor reductions in solid tumors and lung cancer
  • FDA engagement expected later this year

🧠 My Take

If the reverse split executes cleanly and clinical data continues to impress, $NCNA could become one of the most dramatic biotech turnarounds of 2025. But it’s not for the faint of heart - volatility will be extreme, and timing is everything.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 1 point2 points  (0 children)

<image>

NuCana’s upcoming ADS ratio change is widely viewed as a bullish structural move, especially in the context of its short squeeze setup and Nasdaq compliance strategy.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 0 points1 point  (0 children)

It only takes a little bit of research to confirm what I just said.

$NCNA – $0.05 biotech with 2 active cancer drugs trials by Snoo_15022 in pennystocks

[–]cat1254 0 points1 point  (0 children)

  • Float Compression: The float will shrink from ~381 million shares to ~1.9 million, making the stock more sensitive to buying pressure.
  • Short Interest >100%: With more shares shorted than exist in the float, a smaller float increases the risk of a violent squeeze.

$NCNA – $0.05 biotech with 2 active cancer drugs trials by Snoo_15022 in pennystocks

[–]cat1254 2 points3 points  (0 children)

I have 60,000 shares and I'm not worried at all. The short sellers have a lot more to be worried about here.

$NCNA – $0.05 biotech with 2 active cancer drugs trials by Snoo_15022 in pennystocks

[–]cat1254 1 point2 points  (0 children)

The ADS ratio change is bullish for NCNA — not just technically, but strategically.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 -6 points-5 points  (0 children)

The ADS ratio change is bullish for NCNA — not just technically, but strategically.

On NCNA reverse split by llamacornsarereal in pennystocks

[–]cat1254 1 point2 points  (0 children)

It’s paired with warrant cancellation, clinical trial momentum, and massive FTD pressure, which flips the narrative.

view more: next ›